Literature DB >> 30843888

CAR T-cell therapy against B-cell maturation antigen in multiple myeloma.

Adam D Cohen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30843888

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  3 in total

1.  Case Report: ITP Treatment After CAR-T Cell Therapy in Patients With Multiple Myeloma.

Authors:  Mengyi Du; Linlin Huang; Haiming Kou; Chenggong Li; Yu Hu; Heng Mei
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

2.  Anti-CS1 × Anti-CD3 Bispecific Antibody (BiAb)-Armed Anti-CD3 Activated T Cells (CS1-BATs) Kill CS1+ Myeloma Cells and Release Type-1 Cytokines.

Authors:  Lawrence G Lum; Archana Thakur; Abdalla Elhakiem; Lena Alameer; Emily Dinning; Manley Huang
Journal:  Front Oncol       Date:  2020-05-05       Impact factor: 6.244

3.  Chimeric antigen receptor T-cell therapy for multiple myeloma: a consensus statement from The European Myeloma Network.

Authors:  Philippe Moreau; Pieter Sonneveld; Mario Boccadoro; Gordon Cook; Ma Victoria Mateos; Hareth Nahi; Hartmut Goldschmidt; Meletios A Dimopoulos; Paulo Lucio; Joan Bladé; Michel Delforge; Roman Hajek; Heinz Ludwig; Thierry Facon; Jesus F San Miguel; Hermann Einsele
Journal:  Haematologica       Date:  2019-08-22       Impact factor: 9.941
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.